Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11932882 Reverse transcriptase variants

Patent 11932882 was granted and assigned to 10X Genomics on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Derek Hunter Vallejo0

Sonya A. Clark0

Katherine Pfeiffer0

Carolina Cuellar0

Date of Patent

March 19, 2024

0

Patent Application Number

178374970

Date Filed

June 10, 2022

0

Patent Citations

US Patent 8753845 Thermostable reverse transcriptases and uses thereof

0

US Patent 8541219 High fidelity reverse transcriptases and the uses thereof

0

US Patent 9580698 Mutant reverse transcriptase

0

Patent Primary Examiner

Christian L Fronda

0

Patent abstract

The application provides compositions including engineered reverse transcriptases with at least one altered reverse-transcriptase related activity. The engineered reverse transcriptases or reverse transcription enzymes unexpectedly exhibit one or more altered reverse transcriptase related activities such as but not limited to altered template switching efficiency, altered transcription efficiency or both.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11932882 Reverse transcriptase variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool